Clonal evolution in tyrosine kinase inhibitor-resistance: lessons from in vitro-models

INTRODUCTION: Resistance in anti-cancer treatment is a result of clonal evolution and clonal selection. In chronic myeloid leukemia (CML), the hematopoietic neoplasm is predominantly caused by the formation of the BCR::ABL1 kinase. Evidently, treatment with tyrosine kinase inhibitors (TKIs) is treme...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaehler, Meike, Osteresch, Pia, Künstner, Axel, Vieth, Stella Juliane, Esser, Daniela, Möller, Marius, Busch, Hauke, Vater, Inga, Spielmann, Malte, Cascorbi, Ingolf, Nagel, Inga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294234/
https://www.ncbi.nlm.nih.gov/pubmed/37384296
http://dx.doi.org/10.3389/fonc.2023.1200897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294234/
https://www.ncbi.nlm.nih.gov/pubmed/37384296
http://dx.doi.org/10.3389/fonc.2023.1200897

Ejemplares similares